Neurotrophin and Trk expression by cells of the human lamina cribrosa following oxygen-glucose deprivation
© Lambert et al; licensee BioMed Central Ltd. 2004
Received: 08 July 2004
Accepted: 03 December 2004
Published: 03 December 2004
Ischemia within the optic nerve head (ONH) may contribute to retinal ganglion cell (RGC) loss in primary open angle glaucoma (POAG). Ischemia has been reported to increase neurotrophin and high affinity Trk receptor expression by CNS neurons and glial cells. We have previously demonstrated neurotrophin and Trk expression within the lamina cribrosa (LC) region of the ONH. To determine if ischemia alters neurotrophin and Trk protein expression in cells from the human LC, cultured LC cells and ONH astrocytes were exposed to 48 hours of oxygen-glucose deprivation (OGD). Also cells were exposed to 48 hours of OGD followed by 24 hours of recovery in normal growth conditions. Cell number, neurotrophin and Trk receptor protein expression, neurotrophin secretion, and Trk receptor activation were examined.
Cell number was estimated using an assay for cell metabolism following 24, 48 and 72 hours of OGD. A statistically significant decrease in LC and ONH astrocyte cell number did not occur until 72 hours of OGD, therefore cellular protein and conditioned media were collected at 48 hours OGD. Protein expression of NGF, BDNF and NT-3 by LC cells and ONH astrocytes increased following OGD, as did NGF secretion. Recovery from OGD increased BDNF protein expression in LC cells. In ONH astrocytes, recovery from OGD increased NGF protein expression, and decreased BDNF secretion. Trk A expression and activation in LC cells was increased following OGD while expression and activation of all other Trk receptors was decreased. A similar increase in Trk A expression and activation was observed in ONH astrocytes following recovery from OGD.
In vitro conditions that mimic ischemia increase the expression and secretion of neurotrophins by cells from the ONH. Increased Trk A expression and activation in LC cells following OGD and in ONH astrocytes following recovery from OGD suggest autocrine/paracrine neurotrophin signaling could be a response to ONH ischemia in POAG. Also, the increase in NGF, BDNF and NT-3 protein expression and NGF secretion following OGD also suggest LC cells and ONH astrocytes may be a paracrine source of neurotrophins for RGCs.
Glaucoma is an optic neuropathy defined by characteristic optic nerve head and associated visual field changes. Nearly 67 million people worldwide are believed to have glaucoma, including an estimated 2.2 million in the USA [1, 2]. Primary open-angle glaucoma (POAG) is the most common form of glaucoma accounting for virtually half of all cases . The visual field changes associated with POAG are due to the loss of retinal ganglion cells (RGCs), which is proposed to occur via apoptosis [4, 5]. There is evidence that ischemia contributes to RGC loss in glaucoma. Abnormal optic nerve head (ONH) and retinal blood flow has been observed in glaucoma, and retinal ischemia results in RGC loss [6–11]. In addition, excitotoxicity due to elevated glutamate levels, which occurs following ischemia, can cause RGC death [12–16]. However, not all cellular responses to ischemia are deleterious. The expression of "protective factors", including neurotrophins (NTs), by neurons and glia within the CNS has been shown to increase following ischemia [17–19].
Neurotrophins are polypeptide growth factors involved in the development and maintenance of neurons, as well as non-neuronal cells. Included in this family of trophic factors are nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin 4 (NT-4). Neurotrophin signaling occurs via two types of receptors including (a) tyrosine kinase high affinity Trk receptors and (b) the low affinity p75 receptor . The Trk receptors include Trk A, Trk B and Trk C that bind NGF, BDNF and NT-4, and NT-3 respectively . Truncated isoforms of Trk B and Trk C that lack the tyrosine kinase domain have been identified and their function at this time is unknown, although there is evidence that these receptors interfere with full-length trk signaling through ligand sequestration [22–24].
In addition to their localization at axon terminals, Trk receptors have been localized at neuronal cell bodies, at dendritic projections, and along axons [25–27]. Discrete signaling pathways can be activated and distinct biological responses elicited in neurons depending on the location of Trk receptor stimulation indicating neurons respond not only to retrograde NT sources, but also to paracrine and autocrine sources [28–31]. The lamina cribrosa (LC) region of the optic nerve head (ONH) is composed of connective tissue plates that align to form a sieve-like structure that guides and protects RGC axons as they exit the eye to form the optic nerve. Two major cell types have been isolated from the human LC and include ONH astrocytes and LC cells [32–35]. We have previously demonstrated the expression of NTs and their Trk receptors by cells isolated from the human LC . We also reported that mRNA and protein for the low affinity p75 receptor are not expressed by cells isolated from the human ONH. In addition we have shown that LC cells and ONH astrocytes can respond to exogenous NTs via Trk phosphorylation resulting in cell proliferation and secretion of NTs . Due to the proximity of LC cells and ONH astrocytes to RGC axons within the LC, these cells could serve as a paracrine source of NTs for RGCs.
The administration of exogenous NTs has been shown to protect neurons from ischemic damage [38, 39] suggesting endogenous NT sources could also be neuroprotective. A recent report by Rudzinski et al. demonstrated that ocular hypertension increased NGF and BDNF expression within the retina . Furthermore, Trk A expression in the retina was increased following elevated intraocular pressure (IOP), and this increase was observed in RGCs. Cui et al. observed an increase in Trk A, Trk B and Trk C expression in RGCs following optic nerve injury , again suggesting a neuroprotective role for NTs in RGC injury.
In POAG, the laminar plates of the LC are compressed and bow backward from the sclera producing an excavated and exaggerated optic cup . Because capillaries within the LC are located in the connective tissue plates , elevated IOP would likely compromise the blood flow to the LC. Ischemic insults during the progression of POAG could increase the expression and/or secretion of NTs from LC cells and ONH astrocytes, thereby increasing paracrine and/or autocrine NT signaling within the LC.
Given that ischemia can be a component of ocular hypertension, we used oxygen-glucose deprivation (OGD) as an acute model of in vitro ischemia and examined the expression of NTs and their receptors by cultured LC cells and ONH astrocytes following OGD. We are aware that the model used (oxygen and glucose deprivation) is not a perfect model for what occurs in the glaucomatous optic nerve head. However, this acute model was an attempt to mimic the end results of a chronic condition, and as a "first step" we felt this model was adequate for examining the response to injury in these cell types.
Cell number following oxygen-glucose deprivation
The LC and ONH astrocyte cell lines used in this study have been previously characterized and described . Preliminary studies examining cell survival following anoxia, hypoxia, hypoglycemia or serum withdrawl demonstrated LC cells and ONH astrocytes were resistant to hypoxia and serum withdrawl alone (data not shown). To approach what is occurring in vivo, we used the more acute oxygen-glucose deprivation (OGD) model to examine NT and trk expression, and NT signaling in cells from the ONH.
Neurotrophin protein expression following oxygen-glucose deprivation
As seen in Figure 2, the overall trend following 48 hours of OGD was a decrease in NT protein expression by LC cells. The exceptions to this trend were NGF (58 kDa), BDNF (78 kDa), and NT-3 (57 kDa), of which only NT-3 (57 kDa) demonstrated a statistically significant increase in protein expression following OGD. Of the remaining NT isoforms, BDNF (67 kDa) and NT-4 (69 kDa) demonstrated a statistically significant decrease in expression following OGD. A recovery period of 24 hours in growth media and an aerobic environment following 48 hours OGD resulted in elevated NT protein expression by LC cells, however only BDNF (67 kDa) expression levels were statistically significant.
Summary of western blot densitometry data expressed in percent of the control ± SEM of three cell lines.
Lamina cribrosa cells
NGF (71 kDa)
16 ± 7
162 ± 71
14 ± 4
118 ± 7
NGF (58 kDa)
264 ± 67
106 ± 3
157 ± 18
122 ± 39
BDNF (78 kDa)
1244 ± 414
265 ± 152
288 ± 75
78 ± 20
BDNF (67 kDa)
22 ± 6
151 ± 22
22 ± 9
121 ± 13
NT-3 (78 kDa)
57 ± 12
120 ± 52
145 ± 13
129 ± 32
NT-3 (57 kDa)
213 ± 37
77 ± 20
188 ± 22
126 ± 32
NT-4 (69 kDa)
8 ± 7
119 ± 30
4 ± 3
117 ± 30
NT-4 (54 kDa)
32 ± 13
98 ± 35
44 ± 12
85 ± 13
175 ± 15
54 ± 12
53 ± 7
178 ± 21
25 ± 9
150 ± 24
57 ± 38
157 ± 33
46 ± 9
63 ± 7
25 ± 7
73 ± 3
65 ± 16
132 ± 26
40 ± 8
99 ± 7
pTrk (148 kDa)
23 ± 9
37 ± 10
12 ± 10
59 ± 16
pTrk (120 kDa)
162 ± 16
93 ± 8
19 ± 14
204 ± 19
pTrk (80 kDa)
80 ± 14
92 ± 12
6 ± 4
104 ± 18
pTrk (72 kDa)
13 ± 7
70 ± 18
4 ± 3
77 ± 13
Trk receptor protein expression following oxygen-glucose deprivation
Phosphorylated Trk receptor protein expression following oxygen-glucose deprivation
Overall, exposure to OGD resulted in decreased phospho-Trk protein expression by LC cells and ONH astrocytes. Expression of the 148 kDa phospho-trk isoform was decreased to a statistically significant level in both LC cells and ONH astrocytes, as was the 120 kDa and 80 kDa isoforms in ONH astrocytes. The only increase in phospho-Trk receptor protein expression following OGD was observed in LC cells. Protein expression of the 120 kDa phospho-Trk receptor isoform was increased 60% over the controls in LC cells, which was statistically significant.
Recovery from OGD resulted in increased protein expression of phospho-Trk receptor isoforms in LC cells and ONH astrocytes when compared to OGD alone, with the exception of the 120 kDa isoform in LC cells, which decreased toward control levels. Although its expression increased compared to OGD alone, expression of the 148 kDa isoform was still decreased to a significant level. Interestingly, the 120 kDa phospho-trk isoform was again the only isoform whose expression was increased above control levels. This 100% increase was observed in ONH astrocytes following recovery from OGD and was statistically significant.
Neurotrophin secretion following oxygen-glucose deprivation
Lamina cribrosa cell and ONH astrocyte responses to oxygen-glucose deprivation.
Lamina cribrosa cells
95 % survival at 24 hrs, 85% at 48 hrs
70 % survival at 24 hrs, 80% at 48 hrs
↑ NGF, ↑ BDNF, ↑ NT-3; ↓ NT-4
↑ BDNF, ↑ NT-3; ↓ NGF, ↓ NT-4
↑ Trk A; ↓ Trk C, ↓ Trk B
↓ Trk A, ↓ Trk C, ↓ Trk B.T
↑ 120 kDa isoform (Trk A); ↓ 148 kDa isoform
↓ all phospho-trk receptors
Secretion of NTs
↑ NGF; ↓ BDNF
↑ NGF; ↓ BDNF
Lamina cribrosa cell and ONH astrocyte responses to recovery following oxygen-glucose deprivation.
Lamina cribrosa cells
80 % survival
80 % survival
↑ BDNF; others near control levels
↓ Trk A, ↓ Trk C
↑ Trk A
↓ 148 kDa isoform; others near control levels
↑ 120 kDa isoform (Trk A); ↓ 148 kDa isoform
Secretion of NTs
near control levels
Ischemia due to elevated IOP during POAG may cause changes within the ONH and contribute to RGC loss [6–11]. As a response to ischemia, neurons and glia have been shown to increase the expression of NTs [17–19]. Local NT sources for RGCs within the retina and LC could potentially protect these neurons during periods of ONH ischemia in POAG. The recent report of Rudzinski et al.  is of interest as they demonstrated an up-regulation of both NGF and Trk A after 7 days of ocular hypertension, and a sustained up-regulation of BDNF after 28 days elevated IOP. We have previously demonstrated NT expression and secretion by LC cells and ONH astrocytes . The LC region of the ONH and the cells that reside there may be subject to ischemic injury during the progression of POAG. Therefore, we examined cell number as determined by cell metabolism following OGD to determine if LC cells and ONH astrocytes could survive ischemic insult. Lamina cribrosa cell metabolism/cell number remained within 15% of the controls until 72 hours of OGD, whereas ONH astrocyte cell metabolism/cell number decreased 20–30% over the same exposure time. Lamina cribrosa and ONH astrocyte cell metabolism/cell number returned to within 20% of the controls following recovery from OGD. These results suggest LC cells and ONH astrocytes can survive ischemic injury and therefore could be a potential source of neuroprotective factors.
Neurons, including RGCs, express Trk receptors not only at the axon terminal and cell body, but also along their axons [25–27] suggesting RGCs could bind NTs provided by cells of the ONH. We examined the expression and secretion of NTs by LC cells and ONH astrocytes following OGD to determine if these cells could potentially protect RGCs from ischemic injury. The expression of NGF, BDNF and NT-3 by LC cells and ONH astrocytes increased after exposure to OGD. Examination of NT mRNA levels in LC cells and ONH astrocytes following OGD would determine whether this is due to an up-regulation in expression or to increased processing of proNTs. Interestingly, only NGF secretion by LC cells and ONH astrocytes was increased by OGD. It is possible that BDNF and NT-3 are secreted by LC cells and ONH astrocytes following OGD, but at time points other than those examined or at lower detection levels. Overall, the responses to OGD by LC cells and ONH astrocytes with respect to the expression of NTs appeared favorable to RGCs. Neurotrophin expression was increased in both cell types, as was NGF secretion. Thus it appears LC cells and ONH astrocytes could provide RGCs with neuroprotective factors following ischemic injury.
The expression of Trk receptors (both full length and truncated) by LC cells, ONH astrocytes or other cells within the LC could limit NT availability to RGCs [22–24]. Therefore, we examined Trk protein expression and activation in LC cells and ONH astrocytes following OGD. Trk receptor expression was decreased in LC cells and ONH astrocytes following OGD, with the significant exception of Trk A in LC cells. As an indication of NT signaling, we examined the expression of phosphorylated Trk receptors in LC cells and ONH astrocytes following OGD. Phospho-Trk A expression in LC cells was increased after OGD, while all other phospho-Trk expression was decreased. The up-regulation of autocrine NGF signaling in LC cells (e.g. NGF secretion and Trk A expression) could explain the differences observed between LC and ONH astrocyte cell number in following OGD. In a previous report we demonstrated that exogenous NGF increased LC cell number . As LC cells do not express p75, this response is most likely due to Trk A activation. Together these data suggest Trk expression by ONH astrocytes would not interfere with NT availability to RGCs during ischemia. In contrast, increased expression of Trk A in LC cells resulted in increased Trk A activation, implying NGF expression in these cells during ischemia may be self protective rather than protective toward RGCs.
There is evidence that reperfusion following ischemia is actually more detrimental to cells than ischemia itself [45, 46]. To determine if cells from the LC could provide RGCs with NT support during reperfusion of the ONH in POAG, we examined NT and Trk receptor expression following recovery from OGD. ONH astrocytes could be a source of NTs for RGCs during reperfusion of the ONH as an increase in NGF protein expression was observed in these cells after recovery from OGD. However, recovery from OGD also increased Trk A expression and activation in ONH astrocytes, implying these cells up-regulate autocrine/paracrine NGF signaling during recovery from an ischemic event. In addition, Trk B receptor expression by LC cells and ONH astrocytes increased after recovery from OGD suggesting NT availability to RGC axons within the LC may be compromised during ONH reperfusion. Based on these results, LC cells and ONH astrocytes would be unable to provide RGCs with NTs during reperfusion of the ONH. Increased NT expression by LC cells and ONH astrocytes during ONH ischemia could protect RGCs from injury; however, as blood flow was restored NT expression by LC cells and ONH astrocytes would decrease to normal levels, leaving RGCs vulnerable to injury. Neurotrophin expression by LC cells and ONH astrocytes may be beneficial to RGCs during ischemia, but may be unable to promote the survival of these neurons during reperfusion.
In conclusion, we have demonstrated that LC cells and ONH astrocytes increase the expression of NGF, BDNF and NT-3 protein following OGD, which may be neuroprotective for RGCs. Neurotrophins expressed by LC cells and ONH astrocytes following OGD or recovery from OGD bind and activate Trk receptors expressed by these cells. Increased NT signaling within LC cells and ONH astrocytes could increase cell survival following ischemic injury, but may compromise RGC survival during reperfusion. Further studies examining the expression of NTs and Trk receptors following hypoxia or transient ischemic insults would provide a better model for ischemic injury in POAG. Using this model, RGCs could be co-cultured with LC cells or ONH astrocytes to determine the neuroprotective effects of NTs during ischemic injury. By better understanding NT signaling within the LC under normal and injurious conditions, new strategies involving these factors could be developed to better treat patients with POAG.
Lamina cribrosa cells and ONH astrocytes respond to conditions that mimic ONH ischemia by increasing NGF, BDNF and NT-3 protein expression and NGF secretion.
Increased protein expression of Trk receptors and phosphorylated Trk receptors by LC cells and ONH astrocytes following OGD and recovery from OGD respectively suggest paracrine and/or autocrine NT signaling occurs within the ONH following ischemic injury.
Lamina cribrosa cells and ONH astrocytes may be a paracrine source of NGF, BDNF and/or NT-3 for RGCs, especially during ischemic injury within the ONH throughout POAG progression.
DMEM and fetal bovine serum (FBS) were purchased from HyClone Labs, Logan, UT. The following materials were purchased from Gibco BRL Life Technologies, Grand Island, NY; glucose free DMEM, L-glutamine, penicillin/streptomycin and fungizone (amphotericin B). Costar 96-well plates and Nunc ELISA/EIA 96 well Maxisorp plates were purchased from Fisher Scientific, Pittsburgh, PA. Polyclonal antibodies to Trk A, Trk B, Trk C, truncated Trk B (Trk B.T) and phosphorylated Trk were purchased from Santa Cruz Biotechnology Inc, Santa Cruz, CA. CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assays and Emax™ ImmunoAssay Systems specific for NGF, BDNF, NT-3 and NT-4 were purchased from Promega Corporation, Madison, WI.
Lamina cribrosa and ONH astrocyte cell culture
Lamina cribrosa and ONH astrocyte cell lines were obtained from human LC explants from separate donors as described previously . Cells were cultured in Ham's F-10 Media (LC cells, JRH Biosciences, Lenexa, KS) or DMEM (ONH astrocytes) supplemented with 10% FBS, L-glutamine (0.292 mg/ml), penicillin (100 units/ml)/streptomycin (0.1 mg/ml), and amphotericin B (4 μg/ml) as previously described. Cells were passaged using a 0.25% trypsin solution (Sigma-Aldrich, St. Louis, MO). All cultures were maintained in 5% CO2/95% air at 37°C and media was changed every 2 to 3 days. Characterization of these cells was performed as described previously . Cells expressing α-smooth muscle actin that did not express glial fibrillary acidic protein (GFAP) were characterized as LC cells [32, 33, 36]. Cells expressing GFAP and neural cell adhesion molecule (N-CAM) were characterized as ONH astrocytes [34–36]. Both cell types expressed extracellular matrix proteins, such as collagen I, collagen III, collagen IV and elastin [32, 33, 36]. Adult cell lines from donors whose ages ranged from 39 years to 90 years were used in the following experiments.
Preliminary studies examining cell survival following anoxia, hypoxia, hypoglycemia or serum withdrawl demonstrated LC cells and ONH astrocytes were resistant to hypoxia and serum withdrawl alone (data not shown). To approach what is occurring in vivo, we used the more acute oxygen-glucose deprivation (OGD) model to examine NT and trk expression and NT signaling in cells from the ONH. Preconfluent, age-matched adult LC cells and ONH astrocytes were treated with serum free media for 24 hours. Oxygen-glucose deprivation (OGD) was achieved by culturing LC cells and ONH astrocytes in glucose free serum free DMEM in an anoxic incubator (95% N2/5% CO2) for 48 hours. The oxygen level within the anoxic incubator was measured using a Oxygen Test Kit (Bacharach Inc., Pittsburgh, PA) and was determined to be below detectable levels. Recovery following OGD was achieved by placing cells in OGD conditions for 48 hours and then allowing them to recover in growth media (Ham's F-10 Media or DMEM plus 10% FBS) and an aerobic environment (95% air/5% CO2) for 24 hours. Cells cultured in growth media and an aerobic environment for served as controls.
Determination of cell number based upon cell metabolism following oxygen-glucose deprivation
Adult LC cells and ONH astrocytes were trypsinized, counted using a hemacytometer and plated into Costar 96-well plates at a density of 1,000 cells/well. Cells were allowed to attach overnight and were then placed in serum free media for 24 hours. Lamina cribrosa cells and ONH astrocyte were exposed to OGD as described above for 24, 48 or 72 hours. Recovery following OGD was achieved by placing cells in OGD conditions for 24 or 48 hours and then allowing them to recover in growth media and an aerobic environment (95% air/5% CO2) for 24 hours. Cells cultured in growth media and an aerobic environment for served as controls.
Cell number was estimated using the CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay which measures product from a metabolic process to estimate cell number. Following exposure to OGD or recovery from OGD, media was removed and replaced with 100 μl of serum free media. Twenty microliters of MTS/PMS solution was added to each well. Plates were incubated at 95% air/5% CO2 at 37°C for 1 hour, at which time the absorbance at 490 nm was read using a SpectraMax® 190 microplate reader and Softmax® Pro (Molecular Devices Corporation, Sunnyvale, CA). Metabolically active cells convert MTS into formazan, which is soluble in aqueous solutions. The quantity of the formazan product measured by the amount of absorbance at 490 nm is therefore directly proportional to the number of living cells. Cell metabolism/cell number per well was calculated from a standard curve generated using known amounts of cells per well. A standard curve was generated for each cell line assayed. Three LC cell lines and three ONH astrocyte cell lines were assayed. The entire experiment, including standard curves, was repeated twice. Changes in cell metabolism/cell number following OGD and recovery from OGD were reported as a percent of the control ± SEM.
Protein extraction and western blot analysis
Cellular protein was collected in lysis buffer modified from Watson et al.  [20 mM Tris (pH 7.4), 137 mM NaCl, 1% NP40, 10% glycerol, 48 mM sodium fluoride, 16 mM sodium pyrophosphate, 1 mM PMSF, 20 μM leupeptin, 10 μg/ml aprotinin, and 1 mM sodium orthovanadate (10 μl/ml)]. Protein concentration was measured using the Bio-Rad Dc Protein Assay System (Bio-Rad Laboratories, Richmond, CA). Cellular lysate (50 μg) was separated on denaturing polyacrylamide gels and then transferred by electrophoresis to nitrocellulose membranes. Blots were processed using primary antibodies and the Western Breeze Chemiluminescent Immunodetection System (Invitrogen, Carlsbad, CA). Blots were then exposed to Hyperfilm-ECL (Amersham, Arlington Heights, IL) for various times depending on the amount of target protein present. The density (O.D. × mm2) of unsaturated bands was measured using the Discovery Series scanner and the Diversity One program from pdi (Huntington, NY) and a digital Venturis FP466 computer (Compaq, Houston, TX). Western blots for NTs and trks were stripped and re-probed for β-actin to ensure equal loading.
Conditioned media and immunoassays
Conditioned media was collected and concentrated using Millipore Centriplus YM-3 Centrifugal Filter Devices (Millipore Corporation, Bedford, MA). Emax™ ImmunoAssay Systems specific for NGF, BDNF, NT-3 and NT-4 (Promega) were performed according to manufacturer's instructions. Conditioned media was added to Nunc ELISA/EIA 96 well Maxisorp plates coated with anti-NT polyclonal antibodies. Secreted NT was detected by treating the plates with the respective NT monoclonal antibody followed by a horseradish peroxidase conjugated secondary antibody. Enzyme substrate was added to generate a color product whose absorbance was read at 450 nm. A NT standard included in each assay was used to generate a standard curve that was used to calculate the amount of secreted NT per well. The amount of secreted NT per sample was normalized to total protein per sample. Samples were assayed in triplicate. Conditioned media from three LC cell lines and three ONH astrocyte cell lines were assayed. Each immunoassay was repeated twice. Changes in NT secretion following OGD and recovery from OGD were reported as a percent of the control ± SEM.
Cell metabolism/cell number, western blot densitometry and immunoassay data were analyzed using one way analysis of variance (ANOVA) followed by validation using Student-Newman-Keuls tests. The MedCalc® statistical package, version 7.4.41  was used for statistical analysis. Significance values were adjusted in accordance with Bonferroni's correction for multiple tests .
Research underlying this article was made possible by Alcon Laboratories and National Institute of Health # EY12783. The authors would also like to acknowledge and thank The Glaucoma Foundation for their generous support, The Central Florida Lions Eye and Tissue Bank for ocular tissue, and Sherry English-Wright, Dr. William Howe, and Paula Billman for their technical assistance.
- Quigley HA: Number of people with glaucoma worldwide. Br J Ophthalmol. 1996, 80: 389-393.PubMed CentralView ArticlePubMedGoogle Scholar
- Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J: Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004, 122: 532-538. 10.1001/archopht.122.7.1019.View ArticlePubMedGoogle Scholar
- I.Goldberg: How common is glaucoma worldwide?. Glaucoma in the 21st Century. Edited by: R.N.Weinreb , Y.Kitazawa and G.Krieglstein . 2000, London, Mosby International, 3-8.Google Scholar
- Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ: Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995, 36: 774-786.PubMedGoogle Scholar
- Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC: Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995, 61: 33-44. 10.1016/S0014-4835(95)80056-5.View ArticlePubMedGoogle Scholar
- Kerr J, Nelson P, O'Brien C: A comparison of ocular blood flow in untreated primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 1998, 126: 42-51. 10.1016/S0002-9394(98)00074-9.View ArticlePubMedGoogle Scholar
- Arend O, Plange N, Sponsel WE, Remky A: Pathogenetic aspects of the glaucomatous optic neuropathy: fluorescein angiographic findings in patients with primary open angle glaucoma. Brain Res Bull. 2004, 62: 517-524. 10.1016/j.brainresbull.2003.07.008.View ArticlePubMedGoogle Scholar
- Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, Amoako-Mensah T, Eichler HG, Vass C, Schmetterer L: Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004, 45: 834-839. 10.1167/iovs.03-0461.View ArticlePubMedGoogle Scholar
- Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M: Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996, 37: 2002-2014.PubMedGoogle Scholar
- Lafuente MP, Villegas-Perez MP, Selles-Navarro I, Mayor-Torroglosa S, Miralles I, Vidal-Sanz M: Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 2002, 109: 157-168. 10.1016/S0306-4522(01)00458-4.View ArticlePubMedGoogle Scholar
- Joo CK, Choi JS, Ko HW, Park KY, Sohn S, Chun MH, Oh YJ, Gwag BJ: Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci. 1999, 40: 713-720.PubMedGoogle Scholar
- Swanson RA, Ying W, Kauppinen TM: Astrocyte influences on ischemic neuronal death. Curr Mol Med. 2004, 4: 193-205. 10.2174/1566524043479185.View ArticlePubMedGoogle Scholar
- Nickells RW: Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma. 1996, 5: 345-356.View ArticlePubMedGoogle Scholar
- Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA: Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996, 114: 299-305.View ArticlePubMedGoogle Scholar
- Vorwerk CK, Gorla MS, Dreyer EB: An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol. 1999, 43 Suppl 1: S142-S150. 10.1016/S0039-6257(99)00017-X.View ArticlePubMedGoogle Scholar
- Vorwerk CK, Naskar R, Schuettauf F, Quinto K, Zurakowski D, Gochenauer G, Robinson MB, Mackler SA, Dreyer EB: Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest Ophthalmol Vis Sci. 2000, 41: 3615-3621.PubMedGoogle Scholar
- Kokaia Z, Andsberg G, Yan Q, Lindvall O: Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: evidence for increased synthesis and anterograde axonal transport. Exp Neurol. 1998, 154: 289-301. 10.1006/exnr.1998.6888.View ArticlePubMedGoogle Scholar
- Abiru Y, Katoh-Semba R, Nishio C, Hatanaka H: High potassium enhances secretion of neurotrophic factors from cultured astrocytes. Brain Res. 1998, 809: 115-126. 10.1016/S0006-8993(98)00849-X.View ArticlePubMedGoogle Scholar
- Lee TH, Kato H, Chen ST, Kogure K, Itoyama Y: Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke. 1998, 29: 1687-1696.View ArticlePubMedGoogle Scholar
- Barbacid M: The Trk family of neurotrophin receptors. J Neurobiol. 1994, 25: 1386-1403. 10.1002/neu.480251107.View ArticlePubMedGoogle Scholar
- Patapoutian A, Reichardt LF: Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001, 11: 272-280. 10.1016/S0959-4388(00)00208-7.View ArticlePubMedGoogle Scholar
- Fryer RH, Kaplan DR, Kromer LF: Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro. Exp Neurol. 1997, 148: 616-627. 10.1006/exnr.1997.6699.View ArticlePubMedGoogle Scholar
- Alderson RF, Curtis R, Alterman AL, Lindsay RM, DiStefano PS: Truncated TrkB mediates the endocytosis and release of BDNF and neurotrophin-4/5 by rat astrocytes and schwann cells in vitro. Brain Res. 2000, 871: 210-222. 10.1016/S0006-8993(00)02428-8.View ArticlePubMedGoogle Scholar
- Luikart BW, Nef S, Shipman T, Parada LF: In vivo role of truncated trkb receptors during sensory ganglion neurogenesis. Neuroscience. 2003, 117: 847-858. 10.1016/S0306-4522(02)00719-4.View ArticlePubMedGoogle Scholar
- Okazawa H, Nishiyama K, Kamei M, Washizaki K, Murayama S, Kwak S, Kanazawa I: trk immunoreactivity at neuronal dendrite and cell body. Biochem Biophys Res Commun. 1993, 194: 683-690. 10.1006/bbrc.1993.1876.View ArticlePubMedGoogle Scholar
- Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC: Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol. 1997, 378: 135-157. 10.1002/(SICI)1096-9861(19970203)378:1<135::AID-CNE8>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Jelsma TN, Friedman HH, Berkelaar M, Bray GM, Aguayo AJ: Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve. J Neurobiol. 1993, 24: 1207-1214. 10.1002/neu.480240907.View ArticlePubMedGoogle Scholar
- Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA: Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat Neurosci. 2001, 4: 981-988. 10.1038/nn720.View ArticlePubMedGoogle Scholar
- Lom B, Cogen J, Sanchez AL, Vu T, Cohen-Cory S: Local and target-derived brain-derived neurotrophic factor exert opposing effects on the dendritic arborization of retinal ganglion cells in vivo. J Neurosci. 2002, 22: 7639-7649.PubMedGoogle Scholar
- Zhang Y, Moheban DB, Conway BR, Bhattacharyya A, Segal RA: Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J Neurosci. 2000, 20: 5671-5678.PubMedGoogle Scholar
- Heerssen HM, Segal RA: Location, location, location: a spatial view of neurotrophin signal transduction. Trends Neurosci. 2002, 25: 160-165. 10.1016/S0166-2236(02)02144-6.View ArticlePubMedGoogle Scholar
- Hernandez MR, Igoe F, Neufeld AH: Cell culture of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 1988, 29: 78-89.PubMedGoogle Scholar
- Clark AF, Browder SL, Steely HT, Wilson K, Cantu-Crouch D, McCartney MD: Cell biology of the human lamina cribrosa. Optic nerve in glaucoma. Edited by: Drance SM. 1995, Amsterdam, Kugler Publications, 79-105.Google Scholar
- Kobayashi S, Vidal I, Pena JD, Hernandez MR: Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia. 1997, 20: 262-273. 10.1002/(SICI)1098-1136(199707)20:3<262::AID-GLIA10>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Ye H, Hernandez MR: Heterogeneity of astrocytes in human optic nerve head. J Comp Neurol. 1995, 362: 441-452. 10.1002/cne.903620402.View ArticlePubMedGoogle Scholar
- Lambert W, Agarwal R, Howe W, Clark AF, Wordinger RJ: Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 2001, 42: 2315-2323.PubMedGoogle Scholar
- Lambert WS, Clark AF, Wordinger RJ: Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa. Mol Vis. 2004, 10: 289-296.PubMedGoogle Scholar
- Han BH, Holtzman DM: BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci. 2000, 20: 5775-5781.PubMedGoogle Scholar
- Zhang Y, Pardridge WM: Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke. 2001, 32: 1378-1384.View ArticlePubMedGoogle Scholar
- Rudzinski M, Wong TP, Saragovi HU: Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension. J Neurobiol. 2004, 58: 341-354. 10.1002/neu.10293.View ArticlePubMedGoogle Scholar
- Cui Q, Tang LS, Hu B, So KF, Yip HK: Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats. Invest Ophthalmol Vis Sci. 2002, 43: 1954-1964.PubMedGoogle Scholar
- Quigley HA: Open-angle glaucoma. N Engl J Med. 1993, 328: 1097-1106. 10.1056/NEJM199304153281507.View ArticlePubMedGoogle Scholar
- Hayreh SS: Blood supply of the optic nerve head. Ophthalmologica. 1996, 210: 285-295.View ArticlePubMedGoogle Scholar
- Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science. 2001, 294: 1945-1948. 10.1126/science.1065057.View ArticlePubMedGoogle Scholar
- Ghiardi GJ, Gidday JM, Roth S: The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vision Res. 1999, 39: 2519-2535. 10.1016/S0042-6989(99)00038-3.View ArticlePubMedGoogle Scholar
- Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM: Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun. 1991, 12-13 Pt 2: 681-689.View ArticlePubMedGoogle Scholar
- Watson FL, Porcionatto MA, Bhattacharyya A, Stiles CD, Segal RA: TrkA glycosylation regulates receptor localization and activity. J Neurobiol. 1999, 39: 323-336. 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4.View ArticlePubMedGoogle Scholar
- MedCalc® statistical package. 2004, [http://www.medcalc.be]
- Uitenbroek D: SISA online statistical analysis, Simple Interactive Statistical Analysis. 2004, [http://home.clara.net/sisa/index.htm]Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.